专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US07932251B2 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives 失效
标题翻译： 6-苯基-1H-咪唑并[4,5-c]吡啶-4-甲腈衍生物
公开(公告)号：US07932251B2
公开(公告)日：2011-04-26
申请号：US12173623
申请日：2008-07-15
申请人： Jiaqiang Cai , Zoran Rankovic , Philip Stephen Jones , David Jonathan Bennett , Xavier Fradera
发明人： Jiaqiang Cai , Zoran Rankovic , Philip Stephen Jones , David Jonathan Bennett , Xavier Fradera
IPC分类号： A61K31/437 , A61K31/438 , A61K31/5377 , C07D471/04 , C07D519/00
CPC分类号： C07D471/04 , C07D519/00
摘要： The present invention relates to 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives having the general Formula I to pharmaceutical compositions comprising the same as well as to the use of these derivatives for the preparation of a medicament for the treatment of cathepsin S related diseases such as atherosclerosis, obesity, inflammation and immune disorders, such as rheumatoid arthritis, psoriasis, cancer, and chronic pain, such as neuropathic pain.
摘要翻译：本发明涉及具有通式I的6-苯基-1H-咪唑并[4,5-c]吡啶-4-甲腈衍生物，其药物组合物包含它们，以及这些衍生物用于制备用于治疗组织蛋白酶S相关疾病如动脉粥样硬化，肥胖症，炎症和免疫疾病如类风湿性关节炎，牛皮癣，癌症和慢性疼痛如神经性疼痛的药物。

2. 发明申请

US20090099172A1 6-PHENYL-1H-IMIDAZO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES 失效
标题翻译： 6-苯基-1H-咪唑并[4,5-c]吡啶-4-羰基衍生物
公开(公告)号：US20090099172A1
公开(公告)日：2009-04-16
申请号：US12173623
申请日：2008-07-15
申请人： Jiaqiang Cai , Zoran Rankovic , Philip Stephen Jones , David Jonathan Bennett , Xavier Fradera
发明人： Jiaqiang Cai , Zoran Rankovic , Philip Stephen Jones , David Jonathan Bennett , Xavier Fradera
IPC分类号： A61K31/437 , C07D471/04 , C07D471/10 , A61P25/00 , A61P19/10 , A61K31/496 , A61K31/438 , A61K31/506 , A61P29/00 , A61K31/5377 , A61K31/4985
CPC分类号： C07D471/04 , C07D519/00
摘要： The present invention relates to 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives having the general Formula I to pharmaceutical compositions comprising the same as well as to the use of these derivatives for the preparation of a medicament for the treatment of cathepsin S related diseases such as atherosclerosis, obesity, inflammation and immune disorders, such as rheumatoid arthritis, psoriasis, cancer, and chronic pain, such as neuropathic pain.
摘要翻译：本发明涉及具有通式I的6-苯基-1H-咪唑并[4,5-c]吡啶-4-甲腈衍生物，其药物组合物包含它们，以及这些衍生物用于制备用于治疗组织蛋白酶S相关疾病如动脉粥样硬化，肥胖症，炎症和免疫疾病如类风湿性关节炎，牛皮癣，癌症和慢性疼痛如神经性疼痛的药物。

3. 发明授权

US07687515B2 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives 失效
标题翻译： 6-苯基-1H-咪唑并[4,5-c]吡啶-4-甲腈衍生物
公开(公告)号：US07687515B2
公开(公告)日：2010-03-30
申请号：US11653600
申请日：2007-01-16
申请人： Jiaqiang Cai , Zoran Rankovic , Philip Stephen Jones , David Jonathan Bennett , Iain Cumming , Jonathan Gillespie
发明人： Jiaqiang Cai , Zoran Rankovic , Philip Stephen Jones , David Jonathan Bennett , Iain Cumming , Jonathan Gillespie
IPC分类号： A61K31/5377 , A61K31/496 , A61K31/4745 , C07D471/02
CPC分类号： C07D471/04
摘要： The present invention relates to 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives having the general Formula I wherein each of the substituents is given the definition as set forth in the specification and claims, pharmaceutical compositions comprising the same as well as to the use of these derivatives for the preparation of a medicament for the treatment of cathepsin S and/or cathepsin K related diseases such as osteoporosis, atherosclerosis, inflammation and immune disorders, such as rheumatoid arthritis, and chronic pain, such as neuropathic pain.
摘要翻译：本发明涉及具有通式I的6-苯基-1H-咪唑并[4,5-c]吡啶-4-腈衍生物，其中每个取代基被给出如说明书和权利要求书中所阐述的定义，药物组合物包括这些以及这些衍生物用于制备用于治疗组织蛋白酶S和/或组织蛋白酶K相关疾病如骨质疏松症，动脉粥样硬化，炎症和免疫疾病如类风湿性关节炎和慢性疼痛的药物的用途，如神经性疼痛。

4. 发明申请

US20120283239A1 1H-[1,2,3]TRIAZOLO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES 有权
标题翻译： 1H- [1,2,3]三唑[4,5-c]吡啶-4-羰基衍生物
公开(公告)号：US20120283239A1
公开(公告)日：2012-11-08
申请号：US13519924
申请日：2011-01-13
申请人： Jiaqiang Cai , David Jonathan Bennett , Philip Stephen Jones
发明人： Jiaqiang Cai , David Jonathan Bennett , Philip Stephen Jones
IPC分类号： C07D471/04 , A61K31/5377 , A61K31/496 , A61K31/54 , A61P25/00 , A61P19/10 , A61P9/10 , A61P29/00 , A61P37/00 , A61P17/06 , A61K31/437 , A61K31/551
CPC分类号： C07D471/04
摘要： The invention relates to 1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derived Cathepsin S inhibitors of Formula (I), wherein R1 is H or (C1-3)alkyl; R2 is halogen or (C1-4)alkyl, optionally substituted with one or more halogens; n is 1-3; X is O or CH2; U, V and W are CH; or one of U, V and W is N; Y is a group capable of interacting with the Sn . . . S2 substites of the active site of Cathepsin S; or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same as well as to the use of these derivatives for the preparation of a medicament for the treatment of cathepsin S related diseases such as atherosclerosis, obesity, inflammation and immune disorders, such as rheumatoid arthritis, psoriasis, cancer, and chronic pain, such as neuropathic pain.
摘要翻译：本发明涉及式（I）的1H- [1,2,3]三唑并[4,5-c]吡啶-4-腈衍生的组织蛋白酶S抑制剂，其中R 1是H或（C 1-3）烷基; R 2是卤素或任选被一个或多个卤素取代的（C 1-4）烷基; n为1-3; X是O或CH2; U，V和W是CH; 或U，V和W之一为N; Y是能够与Sn相互作用的组。。。组织蛋白酶S活性位点的S2位点; 或其药学上可接受的盐用于包含其的药物组合物以及这些衍生物用于制备用于治疗组织蛋白酶S相关疾病如动脉粥样硬化，肥胖症，炎症和免疫疾病如类风湿病的药物中的用途关节炎，牛皮癣，癌症和慢性疼痛，如神经性疼痛。

5. 发明授权

US08026236B2 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives 失效
公开(公告)号：US08026236B2
公开(公告)日：2011-09-27
申请号：US12686692
申请日：2010-01-13
申请人： John Stephen Robinson , Philip Stephen Jones , Jiaqiang Cai , David Jonathan Bennett
发明人： John Stephen Robinson , Philip Stephen Jones , Jiaqiang Cai , David Jonathan Bennett
IPC分类号： A61K37/5377 , A61K31/437 , C07D471/02 , C07D413/14 , A61P19/02 , A61P17/06
CPC分类号： C07D471/04
摘要： The present invention relates to 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives having the general Formula I to pharmaceutical compositions comprising the same as well as to the use of these derivatives for the preparation of a medicament for the treatment of cathepsin S related diseases such as atherosclerosis, obesity, inflammation and immune disorders, such as rheumatoid arthritis, psoriasis, cancer, and chronic pain, such as neuropathic pain.

6. 发明申请

US20100184761A1 6-PHENYL-1H-IMIDAZO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES 失效
标题翻译： 6-苯基-1H-咪唑并[4,5-c]吡啶-4-羰基衍生物
公开(公告)号：US20100184761A1
公开(公告)日：2010-07-22
申请号：US12686692
申请日：2010-01-13
申请人： John Stephen Robinson , Philip Stephen Jones , Jiaqiang Cai , David Jonathan Bennett
发明人： John Stephen Robinson , Philip Stephen Jones , Jiaqiang Cai , David Jonathan Bennett
IPC分类号： A61K31/5377 , C07D471/02 , A61K31/437 , C07D413/14 , A61P19/02 , A61P17/06
CPC分类号： C07D471/04
摘要： The present invention relates to 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives having the general Formula I to pharmaceutical compositions comprising the same as well as to the use of these derivatives for the preparation of a medicament for the treatment of cathepsin S related diseases such as atherosclerosis, obesity, inflammation and immune disorders, such as rheumatoid arthritis, psoriasis, cancer, and chronic pain, such as neuropathic pain.
摘要翻译：本发明涉及具有通式I的6-苯基-1H-咪唑并[4,5-c]吡啶-4-甲腈衍生物，其药物组合物包含它们，以及这些衍生物用于制备用于治疗组织蛋白酶S相关疾病如动脉粥样硬化，肥胖症，炎症和免疫疾病如类风湿性关节炎，牛皮癣，癌症和慢性疼痛如神经性疼痛的药物。

7. 发明授权

US09115126B2 1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivatives 有权
标题翻译： 1H- [1,2,3]三唑并[4,5-c]吡啶-4-甲腈衍生物
公开(公告)号：US09115126B2
公开(公告)日：2015-08-25
申请号：US13519924
申请日：2011-01-13
申请人： Jiaqiang Cai , David Jonathan Bennett , Philip Stephen Jones
发明人： Jiaqiang Cai , David Jonathan Bennett , Philip Stephen Jones
IPC分类号： C07D471/04 , A61K31/5377 , A61K31/496 , A61K31/54 , A61K31/437 , A61K31/551
CPC分类号： C07D471/04
摘要： The invention relates to 1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derived Cathepsin S inhibitors of Formula (I), wherein R1 is H or (C1-3)alkyl; R2 is halogen or (C1-4)alkyl, optionally substituted with one or more halogens; n is 1-3; X is O or CH2; U, V and W are CH; or one of U, V and W is N; Y is a group capable of interacting with the Sn . . . S2 substites of the active site of Cathepsin S; or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same as well as to the use of these derivatives for the preparation of a medicament for the treatment of cathepsin S related diseases such as atherosclerosis, obesity, inflammation and immune disorders, such as rheumatoid arthritis, psoriasis, cancer, and chronic pain, such as neuropathic pain.
摘要翻译：本发明涉及式（I）的1H- [1,2,3]三唑并[4,5-c]吡啶-4-腈衍生的组织蛋白酶S抑制剂，其中R 1是H或（C 1-3）烷基; R2是卤素或任选被一个或多个卤素取代的（C 1-4）烷基; n为1-3; X是O或CH2; U，V和W是CH; 或U，V和W之一为N; Y是能够与Sn相互作用的组。。。组织蛋白酶S活性位点的S2位点; 或其药学上可接受的盐用于包含其的药物组合物以及这些衍生物用于制备用于治疗组织蛋白酶S相关疾病如动脉粥样硬化，肥胖症，炎症和免疫疾病如类风湿病的药物中的用途关节炎，牛皮癣，癌症和慢性疼痛，如神经性疼痛。

8. 发明授权

US06699887B2 Anti-HIV pyrazole derivatives 失效
标题翻译：抗HIV吡唑衍生物
公开(公告)号：US06699887B2
公开(公告)日：2004-03-02
申请号：US09956656
申请日：2001-09-20
申请人： Brian William Dymock , Philip Stephen Jones , John Herbert Merrett , Martin John Parratt
发明人： Brian William Dymock , Philip Stephen Jones , John Herbert Merrett , Martin John Parratt
IPC分类号： C07D23118
CPC分类号： C07D401/06 , A61K31/415 , A61K31/4439 , A61K31/506 , C07D231/18 , C07D231/20 , C07D231/22 , C07D401/12 , C07D403/06 , C07D403/12 , C07D409/06 , C07D413/06
摘要： The present invention comprises novel and known pyrazole derivatives having anti-HIV activity, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds of formula I are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is involved in viral replication. Consequently the compounds of this invention may be advantageously used as therapeutic agents for HIV infection.
摘要翻译：本发明包括具有抗HIV活性的新颖且已知的吡唑衍生物，其制备方法，药物组合物以及这些化合物在医药中的用途。特别地，式I化合物是参与病毒复制的人免疫缺陷病毒逆转录酶的抑制剂。因此，本发明的化合物可有利地用作HIV感染的治疗剂。

9. 发明授权

US07183296B2 Anti-HIV pyrazole derivatives 失效
标题翻译：抗HIV吡唑衍生物
公开(公告)号：US07183296B2
公开(公告)日：2007-02-27
申请号：US10766712
申请日：2004-01-27
申请人： Brian William Dymock , Philip Stephen Jones , John Herbert Merrett , Martin John Parratt
发明人： Brian William Dymock , Philip Stephen Jones , John Herbert Merrett , Martin John Parratt
IPC分类号： A61K31/415 , A61P31/18 , C07D231/18
CPC分类号： C07D401/06 , A61K31/415 , A61K31/4439 , A61K31/506 , C07D231/18 , C07D231/20 , C07D231/22 , C07D401/12 , C07D403/06 , C07D403/12 , C07D409/06 , C07D413/06
摘要： The present invention comprises novel and known pyrazole derivatives having anti-HIV activity, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds of formula I are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is involved in viral replication. Consequently the compounds of this invention may be advantageously used as therapeutic agents for HIV infection.
摘要翻译：本发明包括具有抗HIV活性的新颖且已知的吡唑衍生物，其制备方法，药物组合物以及这些化合物在医药中的用途。特别地，式I化合物是参与病毒复制的人免疫缺陷病毒逆转录酶的抑制剂。因此，本发明的化合物可有利地用作HIV感染的治疗剂。

10. 发明授权

US06018020A Amino acid derivatives 失效
标题翻译：氨基酸衍生物
公开(公告)号：US06018020A
公开(公告)日：2000-01-25
申请号：US96570
申请日：1998-06-12
申请人： Michael Richard Attwood , David Nigel Hurst , Philip Stephen Jones , Paul Brittain Kay , Tony Michael Raynham , Francis Xavier Wilson
发明人： Michael Richard Attwood , David Nigel Hurst , Philip Stephen Jones , Paul Brittain Kay , Tony Michael Raynham , Francis Xavier Wilson
IPC分类号： C12N15/09 , A01N43/34 , A01N43/36 , A61K38/00 , A61P31/12 , A61P31/14 , C07C205/04 , C07C205/45 , C07C271/18 , C07D207/12 , C07D207/20 , C07D211/70 , C07D223/04 , C07D227/04 , C07D405/10 , C07D407/10 , C07D409/10 , C07K7/06 , A61K38/08
CPC分类号： C07K7/06 , A61K38/00
摘要： The invention provides amino acid derivatives of the formula ##STR1## wherein E represents CHO or B(OH).sub.2 ;R.sup.1 represents lower alkyl (optionally substituted by halo, cyano, lower alkylthio, aryl-lower alkylthio, aryl or heteroaryl), lower alkenyl or lower alkynyl;R.sup.2 represents lower alkyl optionally substituted by hydroxy, carboxy, aryl, aminocarbonyl or lower cycloalkyl; andR.sup.3 represents hydrogen or lower alkyl; orR.sup.2 and R.sup.3 together represent di- or trimethylene optionally substituted by hydroxy;R.sup.4 represents lower alkyl (optionally substituted by hydroxy, lower cycloalkyl, carboxy, aryl, lower alkylthio, cyano-lower alkylthio or aryl-lower alkylthio), lower alkenyl, aryl or lower cycloalkyl;R.sup.5 represents lower alkyl (optionally substituted by hydroxy, lower alkylthio, aryl, aryl-lower alkylthio or cyano-lower alkylthio) or lower cycloalkyl;R.sup.6 represents hydrogen or lower alkyl;R.sup.7 represent lower alkyl (optionally substituted by hydroxy, carboxy, aryl or lower cycloalkyl) or lower cycloalkyl;R.sup.8 represents lower alkyl optionally substituted by hydroxy, carboxy or aryl; andR.sup.9 represents lower alkylcarbonyl, carboxy-lower alkylcarbonyl, arylcarbonyl, lower alkylsulphonyl, arylsulphonyl, lower alkoxycarbonyl or aryl-lower alkoxycarbonyl,and salts of acidic compounds of formula I with bases, which are viral proteinase inhibitors useful as antiviral agents, especially for the treatment or prophylaxis of infections caused by Hepatitis C, Hepatitis G and human GB viruses.
摘要翻译：本发明提供下式的氨基酸衍生物，其中E代表CHO或B（OH）2; R 1表示低级烷基（任选被卤素，氰基，低级烷硫基，芳基 - 低级烷硫基，芳基或杂芳基取代），低级烯基或低级炔基; R 2表示任选被羟基，羧基，芳基，氨基羰基或低级环烷基取代的低级烷基; 并且R 3表示氢或低级烷基; 或R 2和R 3一起表示任选被羟基取代的二 - 或三亚甲基; R4代表低级烷基（任选被羟基，低级环烷基，羧基，芳基，低级烷硫基，氰基 - 低级烷硫基或芳基 - 低级烷硫基取代），低级烯基，芳基或低级环烷基; R5代表低级烷基（任选被羟基，低级烷硫基，芳基，芳基 - 低级烷硫基或氰基 - 低级烷硫基取代）或低级环烷基; R6代表氢或低级烷基; R7代表低级烷基（任选被羟基，羧基，芳基或低级环烷基取代）或低级环烷基; R8代表任选被羟基，羧基或芳基取代的低级烷基; 并且R 9表示低级烷基羰基，羧基 - 低级烷基羰基，芳基羰基，低级烷基磺酰基，芳基磺酰基，低级烷氧基羰基或芳基 - 低级烷氧基羰基，以及式I酸性化合物与碱的碱，其为用作抗病毒剂的病毒蛋白酶抑制剂，治疗或预防丙型肝炎，丙型肝炎和人类GB病毒引起的感染。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式